GlassScriptPhysician profile
Mohsin Ali
NPI 1093912909
$2,681.02
in general payments reported to CMS, 2019-2025
38 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,494 · 2020: $294 · 2021: $31.62 · 2022: $36.19 · 2023: $127 · 2024: $585 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.01 |
| Education | $181.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $385.05 | 2019-2024 | Austedo Xr, Austedo |
| Genentech USA, INC. | $252.45 | 2019-2024 | Ocrevus |
| Lilly USA, LLC | $194.83 | 2019-2024 | Amyvid |
| Novartis Pharmaceuticals Corporation | $192.92 | 2019-2024 | |
| Biogen, INC. | $188.88 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $148.69 | 2019-2025 | Ultomiris |
| Ucb, INC. | $99.93 | 2019-2025 | Rystiggo |
| Amgen INC. | $98.73 | 2019-2020 | |
| Abbvie INC. | $89.86 | 2021-2024 | |
| Livanova USA, INC. | $82.45 | 2019-2020 | |
| Emd Serono, INC. | $78.29 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $67.71 | 2019 | |
| Sunovion Pharmaceuticals INC. | $65.15 | 2019-2020 | |
| Genzyme Corporation | $61.87 | 2019-2020 | |
| Kyowa Kirin, INC. | $51.19 | 2024 | Nourianz |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $50.95 | 2024 | |
| Eisai INC. | $47.25 | 2024 | |
| Neurelis, INC. | $43.80 | 2024 | Valtoco |
| Avanir Pharmaceuticals, INC. | $38.50 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $36.97 | 2024 | Nuedexta |
| Mallinckrodt Enterprises LLC | $34.86 | 2019 | |
| Lundbeck LLC | $32.50 | 2025 | Vyepti |
| Csl Behring | $31.08 | 2019-2020 | |
| Grifols USA, LLC | $30.14 | 2019 | |
| Neurocrine Biosciences, INC. | $29.24 | 2019-2025 | |
| Strongbridge US INC. | $27.04 | 2020 | |
| Allergan, INC. | $24.92 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.74 | 2019 | |
| Abiomed | $21.49 | 2024 | Impella |
| Amneal Pharmaceuticals LLC | $19.91 | 2019 | |
| Boston Scientific Corporation | $19.14 | 2022 | |
| Merz North America, INC. | $19.03 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.24 | 2024 | Onpattro |
| Takeda Pharmaceuticals U.S.A., INC. | $16.91 | 2024 | Hyqvia |
| Harmony Biosciences LLC | $16.82 | 2024 | |
| Tanabe Pharma America, INC. | $16.05 | 2020 | |
| Sk Life Science, INC. | $12.60 | 2021 | |
| Acadia Pharmaceuticals INC | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsin Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.